Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
Clinical trial NCT00002659 · UNKNOWN
Trial details
- NCT number
- NCT00002659
- Sponsor
- Matrix Pharmaceutical
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1995-05-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.